James McCaw

James McCaw,

Clin Svc Representative II

Department: Pediatric Genetics and Metabolism
Business Phone: (352) 294-5050
Business Email: jmccaw@ufl.edu

Publications

2024
Key Challenges for Respiratory Virus Surveillance while Transitioning out of Acute Phase of COVID-19 Pandemic.
Emerging infectious diseases. 30(2) [DOI] 10.3201/eid3002.230768. [PMID] 38190760.
2023
A model for malaria treatment evaluation in the presence of multiple species.
Epidemics. 44 [DOI] 10.1016/j.epidem.2023.100687. [PMID] 37348379.
2023
A modelling approach to estimate the transmissibility of SARS-CoV-2 during periods of high, low, and zero case incidence.
eLife. 12 [DOI] 10.7554/eLife.78089. [PMID] 36661303.
2023
Choice of spatial discretisation influences the progression of viral infection within multicellular tissues.
Journal of theoretical biology. 573 [DOI] 10.1016/j.jtbi.2023.111592. [PMID] 37558160.
2023
COVID-19 vaccine coverage targets to inform reopening plans in a low incidence setting.
Proceedings. Biological sciences. 290(2005) [DOI] 10.1098/rspb.2023.1437. [PMID] 37644838.
2023
Cross-sectional study in Madagascar demonstrates efficacy of virtual mentoring and flipped classroom modifications of neonatal resuscitation programme Helping Babies Breathe.
Acta paediatrica (Oslo, Norway : 1992). 112(8):1783-1789 [DOI] 10.1111/apa.16819. [PMID] 37159532.
2023
Enhanced viral infectivity and reduced interferon production are associated with high pathogenicity for influenza viruses.
PLoS computational biology. 19(2) [DOI] 10.1371/journal.pcbi.1010886. [PMID] 36758109.
2023
Forecasting COVID-19 activity in Australia to support pandemic response: May to October 2020.
Scientific reports. 13(1) [DOI] 10.1038/s41598-023-35668-6. [PMID] 37253758.
2023
How effective were Australian Quarantine Stations in mitigating transmission aboard ships during the influenza pandemic of 1918-19?
PLoS computational biology. 19(11) [DOI] 10.1371/journal.pcbi.1011656. [PMID] 38011267.
2023
Improving estimates of waning immunity rates in stochastic SIRS models with a hierarchical framework.
Infectious Disease Modelling. 8(4):1127-1137 [DOI] 10.1016/j.idm.2023.10.002. [PMID] 37886740.
2023
Individual variation in vaccine immune response can produce bimodal distributions of protection.
Vaccine. 41(45):6630-6636 [DOI] 10.1016/j.vaccine.2023.09.025. [PMID] 37793975.
2023
Optimal Interruption of P. vivax Malaria Transmission Using Mass Drug Administration.
Bulletin of mathematical biology. 85(6) [DOI] 10.1007/s11538-023-01153-4. [PMID] 37076740.
2023
Real-time analysis of hospital length of stay in a mixed SARS-CoV-2 Omicron and Delta epidemic in New South Wales, Australia.
BMC infectious diseases. 23(1) [DOI] 10.1186/s12879-022-07971-6. [PMID] 36650474.
2023
Seasonality as a driver of pH1N12009 influenza vaccination campaign impact.
Epidemics. 45 [DOI] 10.1016/j.epidem.2023.100730. [PMID] 38056164.
2023
Superinfection and the hypnozoite reservoir for Plasmodium vivax: a general framework.
Journal of mathematical biology. 88(1) [DOI] 10.1007/s00285-023-02014-3. [PMID] 38040981.
2023
Understanding the impact of disease and vaccine mechanisms on the importance of optimal vaccine allocation.
Infectious Disease Modelling. 8(2):539-550 [DOI] 10.1016/j.idm.2023.05.003. [PMID] 37288288.
2022
A Multiscale Mathematical Model of Plasmodium Vivax Transmission.
Bulletin of mathematical biology. 84(8) [DOI] 10.1007/s11538-022-01036-0. [PMID] 35778540.
2022
COVID-19 in low-tolerance border quarantine systems: Impact of the Delta variant of SARS-CoV-2.
Science advances. 8(14) [DOI] 10.1126/sciadv.abm3624. [PMID] 35394833.
2022
Estimation of the probability of epidemic fade-out from multiple outbreak data.
Epidemics. 38 [DOI] 10.1016/j.epidem.2022.100539. [PMID] 35093850.
2022
Hypnozoite dynamics for Plasmodium vivax malaria: The epidemiological effects of radical cure.
Journal of theoretical biology. 537 [DOI] 10.1016/j.jtbi.2022.111014. [PMID] 35016895.
2022
Rapid assessment of the risk of SARS-CoV-2 importation: case study and lessons learned.
Epidemics. 38 [DOI] 10.1016/j.epidem.2022.100549. [PMID] 35255398.
2021
Antibody Dynamics for Plasmodium vivax Malaria: A Mathematical Model.
Bulletin of mathematical biology. 83(1) [DOI] 10.1007/s11538-020-00837-5. [PMID] 33387082.
2021
Constructing an ethical framework for priority allocation of pandemic vaccines.
Vaccine. 39(5):797-804 [DOI] 10.1016/j.vaccine.2020.12.053. [PMID] 33408013.
2021
Development and Validation of an In Silico Decision Tool To Guide Optimization of Intravenous Artesunate Dosing Regimens for Severe Falciparum Malaria Patients.
Antimicrobial agents and chemotherapy. 65(6) [DOI] 10.1128/AAC.02346-20. [PMID] 33685888.
2021
Development of an influenza pandemic decision support tool linking situational analytics to national response policy.
Epidemics. 36 [DOI] 10.1016/j.epidem.2021.100478. [PMID] 34174521.
2021
Modelling the Effect of MUC1 on Influenza Virus Infection Kinetics and Macrophage Dynamics.
Viruses. 13(5) [DOI] 10.3390/v13050850. [PMID] 34066999.
2021
Modelling within-host macrophage dynamics in influenza virus infection.
Journal of theoretical biology. 508 [DOI] 10.1016/j.jtbi.2020.110492. [PMID] 32966828.
2020
An Activation-Clearance Model for Plasmodium vivax Malaria.
Bulletin of mathematical biology. 82(2) [DOI] 10.1007/s11538-020-00706-1. [PMID] 32052192.
2020
Coordinating the real-time use of global influenza activity data for better public health planning.
Influenza and other respiratory viruses. 14(2):105-110 [DOI] 10.1111/irv.12705. [PMID] 32096594.
2020
Coronavirus Disease Model to Inform Transmission-Reducing Measures and Health System Preparedness, Australia.
Emerging infectious diseases. 26(12):2844-2853 [DOI] 10.3201/eid2612.202530. [PMID] 32985971.
2020
Early analysis of the Australian COVID-19 epidemic.
eLife. 9 [DOI] 10.7554/eLife.58785. [PMID] 32788039.
2020
Estimation of the force of infection and infectious period of skin sores in remote Australian communities using interval-censored data.
PLoS computational biology. 16(10) [DOI] 10.1371/journal.pcbi.1007838. [PMID] 33017395.
2020
Infectious disease pandemic planning and response: Incorporating decision analysis.
PLoS medicine. 17(1) [DOI] 10.1371/journal.pmed.1003018. [PMID] 31917786.
2020
Influencing public health policy with data-informed mathematical models of infectious diseases: Recent developments and new challenges.
Epidemics. 32 [DOI] 10.1016/j.epidem.2020.100393. [PMID] 32674025.
2020
Key questions for modelling COVID-19 exit strategies.
Proceedings. Biological sciences. 287(1932) [DOI] 10.1098/rspb.2020.1405. [PMID] 32781946.
2019
A biological model of scabies infection dynamics and treatment informs mass drug administration strategies to increase the likelihood of elimination.
Mathematical biosciences. 309:163-173 [DOI] 10.1016/j.mbs.2018.08.007. [PMID] 30149021.
2019
A simple influenza model with complicated dynamics.
Journal of mathematical biology. 78(3):607-624 [DOI] 10.1007/s00285-018-1285-z. [PMID] 30155777.
2019
Accounting for Healthcare-Seeking Behaviours and Testing Practices in Real-Time Influenza Forecasts.
Tropical medicine and infectious disease. 4(1) [DOI] 10.3390/tropicalmed4010012. [PMID] 30641917.
2019
Anatomy of a seasonal influenza epidemic forecast.
Communicable diseases intelligence (2018). 43 [DOI] 10.33321/cdi.2019.43.7. [PMID] 30879285.
2019
Modeling the dynamics of Plasmodium falciparum gametocytes in humans during malaria infection.
eLife. 8 [DOI] 10.7554/eLife.49058. [PMID] 31658944.
2019
Sequential infection experiments for quantifying innate and adaptive immunity during influenza infection.
PLoS computational biology. 15(1) [DOI] 10.1371/journal.pcbi.1006568. [PMID] 30653522.
2018
Calculation of the age of the first infection for skin sores and scabies in five remote communities in northern Australia.
Epidemiology and infection. 146(9):1194-1201 [DOI] 10.1017/S0950268818001061. [PMID] 29734959.
2018
Characterization of Influenza B Virus Variants with Reduced Neuraminidase Inhibitor Susceptibility.
Antimicrobial agents and chemotherapy. 62(11) [DOI] 10.1128/AAC.01081-18. [PMID] 30201817.
2018
Clonally diverse CD38+HLA-DR+CD8+ T cells persist during fatal H7N9 disease.
Nature communications. 9(1) [DOI] 10.1038/s41467-018-03243-7. [PMID] 29483513.
2018
Epidemic forecasts as a tool for public health: interpretation and (re)calibration.
Australian and New Zealand journal of public health. 42(1):69-76 [DOI] 10.1111/1753-6405.12750. [PMID] 29281169.
2018
Evidence for Viral Interference and Cross-reactive Protective Immunity Between Influenza B Virus Lineages.
The Journal of infectious diseases. 217(4):548-559 [DOI] 10.1093/infdis/jix509. [PMID] 29325138.
2018
In Silico Investigation of the Decline in Clinical Efficacy of Artemisinin Combination Therapies Due to Increasing Artemisinin and Partner Drug Resistance.
Antimicrobial agents and chemotherapy. 62(12) [DOI] 10.1128/AAC.01292-18. [PMID] 30249691.
2018
Infection-acquired versus vaccine-acquired immunity in an SIRWS model.
Infectious Disease Modelling. 3:118-135 [DOI] 10.1016/j.idm.2018.06.002. [PMID] 30839933.
2018
Investigating the Efficacy of Triple Artemisinin-Based Combination Therapies for Treating Plasmodium falciparum Malaria Patients Using Mathematical Modeling.
Antimicrobial agents and chemotherapy. 62(11) [DOI] 10.1128/AAC.01068-18. [PMID] 30150462.
2018
Investigating Viral Interference Between Influenza A Virus and Human Respiratory Syncytial Virus in a Ferret Model of Infection.
The Journal of infectious diseases. 218(3):406-417 [DOI] 10.1093/infdis/jiy184. [PMID] 29746640.
2018
Predicting the Outcomes of New Short-Course Regimens for Multidrug-Resistant Tuberculosis Using Intrahost and Pharmacokinetic-Pharmacodynamic Modeling.
Antimicrobial agents and chemotherapy. 62(12) [DOI] 10.1128/AAC.01487-18. [PMID] 30249697.
2018
The distribution of the time taken for an epidemic to spread between two communities.
Mathematical biosciences. 303:139-147 [DOI] 10.1016/j.mbs.2018.07.004. [PMID] 30089576.
2018
Within-host modeling of blood-stage malaria.
Immunological reviews. 285(1):168-193 [DOI] 10.1111/imr.12697. [PMID] 30129195.
2017
A Dynamic Stress Model Explains the Delayed Drug Effect in Artemisinin Treatment of Plasmodium falciparum.
Antimicrobial agents and chemotherapy. 61(12) [DOI] 10.1128/AAC.00618-17. [PMID] 28993326.
2017
A mechanistic model quantifies artemisinin-induced parasite growth retardation in blood-stage Plasmodium falciparum infection.
Journal of theoretical biology. 430:117-127 [DOI] 10.1016/j.jtbi.2017.07.017. [PMID] 28728995.
2017
Characterising pandemic severity and transmissibility from data collected during first few hundred studies.
Epidemics. 19:61-73 [DOI] 10.1016/j.epidem.2017.01.004. [PMID] 28189386.
2017
Corrigendum to ”Modelling cross-reactivity and memory in the cellular adaptive immune response to influenza infection in the host” [J.Theor. Biol. 413 (2017) 34-49].
Journal of theoretical biology. 419 [DOI] 10.1016/j.jtbi.2017.03.015. [PMID] 28363398.
2017
Influenza as a trigger for cardiovascular disease: An investigation of serotype, subtype and geographic location.
Environmental research. 156:688-696 [DOI] 10.1016/j.envres.2017.04.024. [PMID] 28477579.
2017
Model selection for seasonal influenza forecasting.
Infectious Disease Modelling. 2(1):56-70 [DOI] 10.1016/j.idm.2016.12.004. [PMID] 29928729.
2017
Modelling cross-reactivity and memory in the cellular adaptive immune response to influenza infection in the host.
Journal of theoretical biology. 413:34-49 [DOI] 10.1016/j.jtbi.2016.11.008. [PMID] 27856216.
2017
Retrospective forecasting of the 2010-2014 Melbourne influenza seasons using multiple surveillance systems.
Epidemiology and infection. 145(1):156-169 [PMID] 27671159.
2017
The Mechanisms for Within-Host Influenza Virus Control Affect Model-Based Assessment and Prediction of Antiviral Treatment.
Viruses. 9(8) [DOI] 10.3390/v9080197. [PMID] 28933757.
2017
Turnover of Village Chickens Undermines Vaccine Coverage to Control HPAI H5N1.
Zoonoses and public health. 64(1):53-62 [DOI] 10.1111/zph.12282. [PMID] 27357237.
2016
Comparison of the Exposure Time Dependence of the Activities of Synthetic Ozonide Antimalarials and Dihydroartemisinin against K13 Wild-Type and Mutant Plasmodium falciparum Strains.
Antimicrobial agents and chemotherapy. 60(8):4501-10 [DOI] 10.1128/AAC.00574-16. [PMID] 27161632.
2016
Forecasting influenza outbreak dynamics in Melbourne from Internet search query surveillance data.
Influenza and other respiratory viruses. 10(4):314-23 [DOI] 10.1111/irv.12376. [PMID] 26859411.
2016
Heightened self-reactivity associated with selective survival, but not expansion, of naïve virus-specific CD8+ T cells in aged mice.
Proceedings of the National Academy of Sciences of the United States of America. 113(5):1333-8 [DOI] 10.1073/pnas.1525167113. [PMID] 26787864.
2016
High conservation level of CD8(+) T cell immunogenic regions within an unusual H1N2 human influenza variant.
Journal of medical virology. 88(10):1725-32 [DOI] 10.1002/jmv.24516. [PMID] 26950895.
2016
Model-Informed Risk Assessment and Decision Making for an Emerging Infectious Disease in the Asia-Pacific Region.
PLoS neglected tropical diseases. 10(9) [DOI] 10.1371/journal.pntd.0005018. [PMID] 27661978.
2016
On the extinction probability in models of within-host infection: the role of latency and immunity.
Journal of mathematical biology. 73(4):787-813 [DOI] 10.1007/s00285-015-0961-5. [PMID] 26748917.
2016
On the Role of CD8+ T Cells in Determining Recovery Time from Influenza Virus Infection.
Frontiers in immunology. 7 [DOI] 10.3389/fimmu.2016.00611. [PMID] 28066421.
2016
Parasite Strain, Host Immunity, and Circulating Blood Cells with Dead Parasites: Why Predicting Malaria Parasite Clearance Is Not a Simple Task.
Antimicrobial agents and chemotherapy. 60(2) [DOI] 10.1128/AAC.02528-15. [PMID] 26826193.
2016
Periodic solutions in an SIRWS model with immune boosting and cross-immunity.
Journal of theoretical biology. 410:55-64 [DOI] 10.1016/j.jtbi.2016.08.034. [PMID] 27575466.
2016
Reducing disease burden in an influenza pandemic by targeted delivery of neuraminidase inhibitors: mathematical models in the Australian context.
BMC infectious diseases. 16(1) [PMID] 27724915.
2015
A new approach to estimating trends in chlamydia incidence.
Sexually transmitted infections. 91(7):513-9 [DOI] 10.1136/sextrans-2014-051631. [PMID] 25564675.
2015
Defining long-term drivers of pertussis resurgence, and optimal vaccine control strategies.
Vaccine. 33(43):5794-5800 [DOI] 10.1016/j.vaccine.2015.09.025. [PMID] 26392008.
2015
Factors associated with transmission of influenza-like illness in a cohort of households containing multiple children.
Influenza and other respiratory viruses. 9(5):247-54 [DOI] 10.1111/irv.12331. [PMID] 26061755.
2015
Innate Immunity and the Inter-exposure Interval Determine the Dynamics of Secondary Influenza Virus Infection and Explain Observed Viral Hierarchies.
PLoS computational biology. 11(8) [DOI] 10.1371/journal.pcbi.1004334. [PMID] 26284917.
2015
Interval Between Infections and Viral Hierarchy Are Determinants of Viral Interference Following Influenza Virus Infection in a Ferret Model.
The Journal of infectious diseases. 212(11):1701-10 [DOI] 10.1093/infdis/jiv260. [PMID] 25943206.
2015
Pertussis models to inform vaccine policy.
Human vaccines & immunotherapeutics. 11(3):669-78 [DOI] 10.1080/21645515.2015.1011575. [PMID] 25714499.
2015
Prior population immunity reduces the expected impact of CTL-inducing vaccines for pandemic influenza control.
PloS one. 10(3) [DOI] 10.1371/journal.pone.0120138. [PMID] 25811654.
2015
Quantifying differences in the epidemic curves from three influenza surveillance systems: a nonlinear regression analysis.
Epidemiology and infection. 143(2):427-39 [DOI] 10.1017/S0950268814000764. [PMID] 24759447.
2015
Quantifying relative within-host replication fitness in influenza virus competition experiments.
Journal of theoretical biology. 382:259-71 [DOI] 10.1016/j.jtbi.2015.07.003. [PMID] 26188087.
2015
Social encounter profiles of greater Melbourne residents, by location–a telephone survey.
BMC infectious diseases. 15 [DOI] 10.1186/s12879-015-1237-9. [PMID] 26525046.
2015
Targeting the cell stress response of Plasmodium falciparum to overcome artemisinin resistance.
PLoS biology. 13(4) [DOI] 10.1371/journal.pbio.1002132. [PMID] 25901609.
2015
The effects of demographic change on disease transmission and vaccine impact in a household structured population.
Epidemics. 13:56-64 [DOI] 10.1016/j.epidem.2015.08.002. [PMID] 26616042.
2014
Dynamical crises, multistability and the influence of the duration of immunity in a seasonally-forced model of disease transmission.
Theoretical biology & medical modelling. 11 [DOI] 10.1186/1742-4682-11-43. [PMID] 25280872.
2014
Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses.
PLoS pathogens. 10(4) [DOI] 10.1371/journal.ppat.1004065. [PMID] 24699865.
2014
Evaluation of oseltamivir prophylaxis regimens for reducing influenza virus infection, transmission and disease severity in a ferret model of household contact.
The Journal of antimicrobial chemotherapy. 69(9):2458-69 [DOI] 10.1093/jac/dku146. [PMID] 24840623.
2014
Making the most of clinical data: reviewing the role of pharmacokinetic-pharmacodynamic models of anti-malarial drugs.
The AAPS journal. 16(5):962-74 [DOI] 10.1208/s12248-014-9647-y. [PMID] 25056904.
2014
Pandemic controllability: a concept to guide a proportionate and flexible operational response to future influenza pandemics.
Journal of public health (Oxford, England). 36(1):5-12 [DOI] 10.1093/pubmed/fdt058. [PMID] 23735960.
2014
Population pharmacokinetics of intravenous artesunate: a pooled analysis of individual data from patients with severe malaria.
CPT: pharmacometrics & systems pharmacology. 3(11) [DOI] 10.1038/psp.2014.43. [PMID] 25372510.
2014
The dynamical consequences of seasonal forcing, immune boosting and demographic change in a model of disease transmission.
Journal of theoretical biology. 361:124-32 [DOI] 10.1016/j.jtbi.2014.07.028. [PMID] 25106793.
2014
The influence of changing host immunity on 1918-19 pandemic dynamics.
Epidemics. 8:18-27 [DOI] 10.1016/j.epidem.2014.07.004. [PMID] 25240900.
2013
Altered temporal response of malaria parasites determines differential sensitivity to artemisinin.
Proceedings of the National Academy of Sciences of the United States of America. 110(13):5157-62 [DOI] 10.1073/pnas.1217452110. [PMID] 23431146.
2013
Antigenic drift of the pandemic 2009 A(H1N1) influenza virus in A ferret model.
PLoS pathogens. 9(5) [DOI] 10.1371/journal.ppat.1003354. [PMID] 23671418.
2013
Reducing uncertainty in within-host parameter estimates of influenza infection by measuring both infectious and total viral load.
PloS one. 8(5) [DOI] 10.1371/journal.pone.0064098. [PMID] 23691157.
2013
Virus detection and its association with symptoms during influenza-like illness in a sample of healthy adults enrolled in a randomised controlled vaccine trial.
Influenza and other respiratory viruses. 7(3):330-9 [DOI] 10.1111/j.1750-2659.2012.00395.x. [PMID] 22712831.
2012
Application of a case-control study design to investigate genotypic signatures of HIV-1 transmission.
Retrovirology. 9 [DOI] 10.1186/1742-4690-9-54. [PMID] 22731404.
2012
Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development.
Malaria journal. 11 [DOI] 10.1186/1475-2875-11-303. [PMID] 22931058.
2012
Drivers and consequences of influenza antiviral resistant-strain emergence in a capacity-constrained pandemic response.
Epidemics. 4(4):219-26 [DOI] 10.1016/j.epidem.2012.12.002. [PMID] 23351374.
2012
Household transmission of respiratory viruses – assessment of viral, individual and household characteristics in a population study of healthy Australian adults.
BMC infectious diseases. 12 [DOI] 10.1186/1471-2334-12-345. [PMID] 23231698.
2012
Influence of contact definitions in assessment of the relative importance of social settings in disease transmission risk.
PloS one. 7(2) [DOI] 10.1371/journal.pone.0030893. [PMID] 22359553.
2012
Likely effectiveness of pharmaceutical and non-pharmaceutical interventions for mitigating influenza virus transmission in Mongolia.
Bulletin of the World Health Organization. 90(4):264-71 [DOI] 10.2471/BLT.11.093419. [PMID] 22511822.
2011
A mathematical framework for estimating pathogen transmission fitness and inoculum size using data from a competitive mixtures animal model.
PLoS computational biology. 7(4) [DOI] 10.1371/journal.pcbi.1002026. [PMID] 21552544.
2011
Diagnosis and antiviral intervention strategies for mitigating an influenza epidemic.
PloS one. 6(2) [DOI] 10.1371/journal.pone.0014505. [PMID] 21346794.
2011
Incorporating population dynamics into household models of infectious disease transmission.
Epidemics. 3(3-4):152-8 [DOI] 10.1016/j.epidem.2011.05.001. [PMID] 22094338.
2011
Understanding mortality in the 1918-1919 influenza pandemic in England and Wales.
Influenza and other respiratory viruses. 5(2):89-98 [DOI] 10.1111/j.1750-2659.2010.00186.x. [PMID] 21306572.
2010
Assessing the viral fitness of oseltamivir-resistant influenza viruses in ferrets, using a competitive-mixtures model.
Journal of virology. 84(18):9427-38 [DOI] 10.1128/JVI.00373-10. [PMID] 20631138.
2010
Comparison of three methods for ascertainment of contact information relevant to respiratory pathogen transmission in encounter networks.
BMC infectious diseases. 10 [DOI] 10.1186/1471-2334-10-166. [PMID] 20537186.
2010
Modelling strategic use of the national antiviral stockpile during the CONTAIN and SUSTAIN phases of an Australian pandemic influenza response.
Australian and New Zealand journal of public health. 34(2):113-9 [DOI] 10.1111/j.1753-6405.2010.00493.x. [PMID] 23331352.
2010
Prior immunity helps to explain wave-like behaviour of pandemic influenza in 1918-9.
BMC infectious diseases. 10 [DOI] 10.1186/1471-2334-10-128. [PMID] 20497585.
2009
Influenza: accounting for prior immunity.
Science (New York, N.Y.). 325(5944):1071; author reply 1072-3 [DOI] 10.1126/science.325_1071a. [PMID] 19713508.
2009
Optimal dosing and dynamic distribution of vaccines in an influenza pandemic.
American journal of epidemiology. 169(12):1517-24 [DOI] 10.1093/aje/kwp072. [PMID] 19395691.
2009
Understanding Australia’s influenza pandemic policy on the strategic use of the antiviral drug stockpile.
The Medical journal of Australia. 191(3):136-7 [PMID] 19645639.
2009
Understanding influenza transmission, immunity and pandemic threats.
Influenza and other respiratory viruses. 3(4):143-9 [DOI] 10.1111/j.1750-2659.2009.00089.x. [PMID] 19627371.
2008
Impact of emerging antiviral drug resistance on influenza containment and spread: influence of subclinical infection and strategic use of a stockpile containing one or two drugs.
PloS one. 3(6) [DOI] 10.1371/journal.pone.0002362. [PMID] 18523549.
2007
A biological model for influenza transmission: pandemic planning implications of asymptomatic infection and immunity.
PloS one. 2(11) [PMID] 18043733.
2007
Prophylaxis or treatment? Optimal use of an antiviral stockpile during an influenza pandemic.
Mathematical biosciences. 209(2):336-60 [PMID] 17416393.

Contact Details

Phones:
Business:
(352) 294-5050
Emails:
Business:
jmccaw@ufl.edu
Addresses:
Business Street:
PO Box 103491
GAINESVILLE FL 32610